EUVIMEDEUVIMED entdecken
Crossref

Acridine/Acridone–Carborane Conjugates as Strong DNA‐Binding Agents with Anticancer Potential

Daria Różycka iD, Aleksandra Kowalczyk iD, Marta Denel-Bobrowska iD, Olga Kuźmycz iD, Magdalena Gapińska iD, Paweł Stączek iD, Agnieszka B Olejniczak iD

ChemMedChem · 03.04.2023 · 18 (7)

DOI: 10.1002/cmdc.202200666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 10.02.2023. Verfasst von Daria Różycka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Screening Laboratory, Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa St., Łódź, 93-232, Poland. Hauptthemen laut MEDLINE: Boranes, Antineoplastic Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Uniwersytet Łódzki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthesis of acridine derivatives that act as DNA‐targeting anticancer agents is an evolving field and has resulted in the introduction of several drugs into clinical trials. Carboranes can be of importance in designing biologically active compounds due to their specific properties. Therefore, a series of novel acridine analogs modified with carborane clusters were synthesized. The DNA‐binding ability of these analogs was evaluated on calf thymus DNA (ct‐DNA). Results of these analyses showed that 9‐[(1,7‐dicarba‐ closo ‐dodecaborane‐1‐yl)propylamino]acridine ( 30 ) interacted strongly with ct‐DNA, indicating its ability to intercalate into DNA, whereas 9‐[(1,7‐dicarba‐ closo ‐dodecaborane‐1‐yl)propanamido]acridine ( 29 ) changed the B‐form of ct‐DNA to the Z form. Compound 30 demonstrated cytotoxicity, was able to inhibit cell proliferation, arrest the cell cycle in the S phase in the HeLa cancer cell line, and induced the production of reactive oxygen species (ROS). In addition, it was specifically localized in lysosomes and was a weak inhibitor of Topo IIα.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BoranesAntineoplastic AgentsAcridinesDNAAcridones

Stichwörter der Autor:innen

acridineacridoneanticancer agentscarboraneintercalation

Substanzen

AcridinesBoranesAntineoplastic AgentsDNAAcridones

Autor:innen und Institutionen

  • Screening Laboratory, Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa St., Łódź, 93-232, Poland.
  • Department of Molecular Microbiology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha St., Łódź, 90-237, Poland.
  • Laboratory of Microscopic Imaging and Specialized Biological Techniques, Faculty of Biology Environmental Protection, University of Lodz, 12/16 Banacha St., Łódź, 90-237, Poland.

ORCID-Profile: Daria Różycka, Aleksandra Kowalczyk, Marta Denel-Bobrowska, Olga Kuźmycz, Magdalena Gapińska, Paweł Stączek, Agnieszka B Olejniczak

Förderung

  • Uniwersytet Łódzki

Zitieren

APA

Różycka, D., Kowalczyk, A., Denel-Bobrowska, M., Kuźmycz, O., Gapińska, M., Stączek, P., & Olejniczak, A. B. (2023). Acridine/Acridone–Carborane Conjugates as Strong DNA‐Binding Agents with Anticancer Potential. ChemMedChem, 18(7). https://doi.org/10.1002/cmdc.202200666

Vancouver

Różycka D, Kowalczyk A, Denel-Bobrowska M, Kuźmycz O, Gapińska M, Stączek P, et al. Acridine/Acridone–Carborane Conjugates as Strong DNA‐Binding Agents with Anticancer Potential. ChemMedChem. 2023;18(7). doi:10.1002/cmdc.202200666

BibTeX
@article{Rycka2023,
  author = {Różycka, Daria and Kowalczyk, Aleksandra and Denel-Bobrowska, Marta and Kuźmycz, Olga and Gapińska, Magdalena and Stączek, Paweł and Olejniczak, Agnieszka B},
  title = {Acridine/Acridone–Carborane Conjugates as Strong DNA‐Binding Agents with Anticancer Potential},
  journal = {ChemMedChem},
  year = {2023},
  volume = {18},
  number = {7},
  doi = {10.1002/cmdc.202200666}
}
Kostenlos starten →